Clinical Trial Update: The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subanesthetic intravenous ketamine for drug-resistant epilepsy is currently recruiting to assess efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy
• Epilepsy

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Madeline Fields | Conditions: Drug Resistant Epilepsy, Medically Refractory Epilepsy | Phase 2 | Status: RECRUITING